APHON Pediatric Chemotherapy-Biotherapy Renewal

! acknowledge the distress that clinicians experience when forced to implement drug allocation decisions that negatively affect individual patients and families ! provide support and therapeutic communication to patients and families whose treatment is altered because of an insufficient drug supply ! become involved in public policy advocacy that strives to minimize drug shortages. Resources on Current Drug Shortages More information is available from the American Society of Health-System Pharmacists (www.ashp.org) and the U.S. Food and Drug Administration (https://www.fda.gov/drugs/drug- safety-and-availability/drug-shortages). Mitigation and Allocation Strategies A 2017 survey that used the membership list of the American Society of Pediatric Hematology/Oncology (ASPHO) was conducted to assess what personnel were involved in scarce drug prioritization and distribution and what criteria were used to inform decisions about the distribution of scarce drugs (Beck et al., 2017). The survey results revealed a significant disparity between respondents’ judgments about how decisions were currently being made and their views on who should be making them ( Table 1 ).